Related references
Note: Only part of the references are listed.Role of protein kinase C-iota in transformed non-malignant RWPE-1 cells and androgen-independent prostate carcinoma DU-145 cells
H. Y. Win et al.
CELL PROLIFERATION (2009)
Atypical protein kinase C phosphorylates IKKαβ in transformed non-malignant and malignant prostate cell survival
Hla Y. Win et al.
CANCER LETTERS (2008)
Involvement of PKC-ι in glioma proliferation
R. Patel et al.
CELL PROLIFERATION (2008)
Androgen receptor and growth factor signaling cross-talk in prostate cancer cells
Meng-Lei Zhu et al.
ENDOCRINE-RELATED CANCER (2008)
The overexpression and altered localization of the atypical protein kinase C λ/ι in breast cancer correlates with the pathologic type of these tumors
Yasuyuki Kojima et al.
HUMAN PATHOLOGY (2008)
Regulation of glioblastoma cell invasion by PKCι and RhoB
R. M. Baldwin et al.
ONCOGENE (2008)
Interleukin-6 and its receptor in cancer - Implications for translational therapeutics
David S. Hong et al.
CANCER (2007)
Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer
L. Tam et al.
BRITISH JOURNAL OF CANCER (2007)
Interleukin-6 undergoes transition from growth inhibitor associated with neuroendocrine differentiation to stimulator accompanied by androgen receptor activation during LNCaP prostate cancer cell progression
Soo Ok Lee et al.
PROSTATE (2007)
Current indications for chemotherapy in prostate cancer patients
Fabio Calabro et al.
EUROPEAN UROLOGY (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Requirement of androgen-dependent activation of protein kinase Cζ for androgen-dependent cell proliferation in LNCaP cells and its roles in transition to androgen-independent cells
Takahiro Inoue et al.
MOLECULAR ENDOCRINOLOGY (2006)
Integrative genomic analysis of protein kinase C (PKC) family identifies PKCι as a biomarker and potential oncogene in ovarian carcinoma
Lin Zhang et al.
CANCER RESEARCH (2006)
Inhibition of interleukin-6 with CNTO328, an anti-interleukin-6 monoclonal antibody, inhibits conversion of androgen-dependent prostate cancer to an androgen-independent phenotype in orchiectomized mice
L Wallner et al.
CANCER RESEARCH (2006)
Cell signaling and function organized by PB1 domain interactions
Jorge Moscat et al.
MOLECULAR CELL (2006)
Atypical protein kinase Cι, is an oncogene in human non-small cell lung cancer
RP Regala et al.
CANCER RESEARCH (2005)
Atypical protein kinase Cι plays a critical role in human lung cancer cell growth and tumorigenicity
RP Regala et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Atypical PKCι contributes to poor prognosis through loss of apical-basal polarity and Cyclin E overexpression in ovarian cancer
AM Eder et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy
SJ Freedland et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Protein kinase Cι is required for Ras transformation and colon carcinogenesis in vivo
NR Murray et al.
JOURNAL OF CELL BIOLOGY (2004)
Bcr-Abl regulates protein kinase Cι (PKCι) transcription via an Elk1 site in the PKCι promoter
WC Gustafson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Androgen receptor: A key molecule in the progression of prostate cancer to hormone independence
ME Taplin et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Role of atypical protein kinase C in estradiol-triggered G1/S progression of MCF-7 cells
G Castoria et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
aPKC acts upstream of PAR-1b in both the establishment and maintenance of mammalian epithelial polarity
A Suzuki et al.
CURRENT BIOLOGY (2004)
Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate
M Royuela et al.
JOURNAL OF PATHOLOGY (2004)
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
PC Heinrich et al.
BIOCHEMICAL JOURNAL (2003)
Interleukin-6: minor player or starring role in the development of hormone-refractory prostate cancer?
NM Corcoran et al.
BJU INTERNATIONAL (2003)
Protein kinase C lambda/iota (PKC lambda/iota): A PKC isotype essential for the development of multicellular organisms
A Suzuki et al.
JOURNAL OF BIOCHEMISTRY (2003)
Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth
Z Culig et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)
Plasma levels of interleukin-6 and its soluble receptor are associated with prostate cancer progression and metastasis
SF Shariat et al.
UROLOGY (2001)
Intercellular junctions and cellular polarity: the PAR-aPKC complex, a conserved core cassette playing fundamental roles in cell polarity
S Ohno
CURRENT OPINION IN CELL BIOLOGY (2001)
NF-κB/RelA transactivation is required for atypical protein kinase Cι-mediated cell survival
Y Lu et al.
ONCOGENE (2001)